Lingotto Investment Management
Lingotto Investment Management is a fund manager in London, UK, investing at Seed, Series A and Series B in North America, with $10.8B AUM. It has an estimated $365.5M in dry powder and a cheque size of $1.6M–$8M. Its latest deals were Multiply Labs, Inc. (Series B, Oct 2026), Robco GmbH (Secondary Stock Purchase, Oct 2026) and Ultraviolette Automotive Private Limited (Series E, Sep 2026).
See if Lingotto Investment Management fits your roundIs your startup a good fit for Lingotto Investment Management?
Est. dry powder
$365.5M
Raised, not yet invested
AUM
$10.8B
Assets under management
Latest fund
$160M
Lingotto Innovation Ventures Fund I
Est. cheque size
$1.6M–
From fund sizes
Deals, last 12 months
16
Last seen investing Oct 2026
About Lingotto Investment Management
Lingotto is an independent investment management company owned by Exor N.V. Established in May 2023, Lingotto exists to deliver attractive long-term returns to its limited partners. Lingotto has four core investment strategies, each led by a Chief Investment Officer or by Managing Partners, and is selectively expanding. Lingotto defines success as ensuring that its assets under management primarily grow through performance rather than capital flows.
- Type
- Fund Manager
- Headquarters
- London, England, UK
- Stages
- SeedSeries ASeries BSeries CSeries DSeries ESeries FSeries G+2
- Est. cheque size
- $1.6M–$8M
- Sectors
- Diversified
- Regions
- Europe, North America
Where they invest
From deals and portfolio companies on record
Most frequent rounds
- Series A8
- Series C6
- Series B5
- Series D3
- Series E3
Across 40 deals
Portfolio sectors
- Biotechnology3
- Financial Services2
- Industrial Machinery2
- Power & Utilities2
- Retail2
Across 23 companies
Portfolio countries
- US9
- India3
- Sweden3
- UK3
- Germany2
Across 23 companies
Recent investments
Newest 5 of 40
- Series B$75M
Multiply Labs, Inc.
Oct 2026 · Series B
- Secondary Stock Purchase$40M
Robco GmbH
Oct 2026 · Secondary Stock Purchase
- Series E$84.9M
Ultraviolette Automotive Private Limited
Sep 2026 · Series E
- Series C$700M
Lumilens Inc.
Aug 2026 · Series C
- Series A$15M
Andromeda Surgical, Inc.
Jul 2026 · Series A
Offices
2 locations
- London, England, UKHQ
- New York, New York, US